Acute coronary syndromes

BA Bergmark, N Mathenge, PA Merlini… - The Lancet, 2022 - thelancet.com
Although substantial progress has been made in the diagnosis and treatment of acute
coronary syndromes, cardiovascular disease remains the leading cause of death globally …

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

B Zhou, P Perel, GA Mensah, M Ezzati - Nature Reviews Cardiology, 2021 - nature.com
High blood pressure is one of the most important risk factors for ischaemic heart disease,
stroke, other cardiovascular diseases, chronic kidney disease and dementia. Mean blood …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis

GO Dibben, J Faulkner, N Oldridge, K Rees… - European heart …, 2023 - academic.oup.com
Aims Coronary heart disease is the most common reason for referral to exercise-based
cardiac rehabilitation (CR) globally. However, the generalizability of previous meta-analyses …

NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4

JE Bennett, V Kontis, CD Mathers, M Guillot, J Rehm… - The Lancet, 2020 - thelancet.com
Summary The Sustainable Development Goal (SDG) target 3.4 is to reduce premature
mortality from non-communicable diseases (NCDs) by a third by 2030 relative to 2015 …

The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1· 1 …

P Geldsetzer, J Manne-Goehler, ME Marcus, C Ebert… - The Lancet, 2019 - thelancet.com
Background Evidence from nationally representative studies in low-income and middle-
income countries (LMICs) on where in the hypertension care continuum patients are lost to …

The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in …

D Flood, JA Seiglie, M Dunn, S Tschida… - The Lancet Healthy …, 2021 - thelancet.com
Background Approximately 80% of the 463 million adults worldwide with diabetes live in low-
income and middle-income countries (LMICs). A major obstacle to designing evidence …

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 …

JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
(GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor …

[HTML][HTML] Vascular tissue engineering: progress, challenges, and clinical promise

HHG Song, RT Rumma, CK Ozaki, ER Edelman… - Cell stem cell, 2018 - cell.com
Although the clinical demand for bioengineered blood vessels continues to rise, current
options for vascular conduits remain limited. The synergistic combination of emerging …

Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals

R Nugent, MY Bertram, S Jan, LW Niessen, F Sassi… - The Lancet, 2018 - thelancet.com
Reduction of the non-communicable disease (NCD) burden is a global development
imperative. Sustainable Development Goal (SDG) 3 includes target 3· 4 to reduce premature …